MX2018002617A - Glucosido hidrolasas y su uso en la prevencion y/o tratamiento de infeccion patogena en un animal. - Google Patents
Glucosido hidrolasas y su uso en la prevencion y/o tratamiento de infeccion patogena en un animal.Info
- Publication number
- MX2018002617A MX2018002617A MX2018002617A MX2018002617A MX2018002617A MX 2018002617 A MX2018002617 A MX 2018002617A MX 2018002617 A MX2018002617 A MX 2018002617A MX 2018002617 A MX2018002617 A MX 2018002617A MX 2018002617 A MX2018002617 A MX 2018002617A
- Authority
- MX
- Mexico
- Prior art keywords
- animal
- pathogenic infection
- glycoside
- alpha
- hydolases
- Prior art date
Links
- 230000001717 pathogenic effect Effects 0.000 title abstract 7
- 208000015181 infectious disease Diseases 0.000 title abstract 3
- 229930182470 glycoside Natural products 0.000 title 1
- 150000002338 glycosides Chemical class 0.000 title 1
- 244000052769 pathogen Species 0.000 abstract 4
- 102000005744 Glycoside Hydrolases Human genes 0.000 abstract 2
- 108010031186 Glycoside Hydrolases Proteins 0.000 abstract 2
- 230000000968 intestinal effect Effects 0.000 abstract 2
- 206010012735 Diarrhoea Diseases 0.000 abstract 1
- 102000012086 alpha-L-Fucosidase Human genes 0.000 abstract 1
- 108010061314 alpha-L-Fucosidase Proteins 0.000 abstract 1
- 150000004676 glycans Chemical group 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/189—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01051—Alpha-L-fucosidase (3.2.1.51)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Animal Husbandry (AREA)
- Food Science & Technology (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Birds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Fodder In General (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Se describen métodos y composiciones que usan glucósido hidrolasas, tales como alfa-L-fucosidasas, para prevenir y/o tratar un infección patógena intestinal y/o diarrea en un animal, en donde la infección patógena está causada por un patógeno capaz de unirse a una cólula intestinal animal en la que la unión de patógeno depende de la presencia de un sitio de unión al patógeno que tiene al menos una estructura de glicano sustituida con al menos un resto alfa-1, 2-L_fucosa que comprende administrar al animal una cantidad eficaz de una glucósido hidrolasa capaz de eliminar el al menos un resto alfa-1-, 2-L-fucosa del sitio de unión al patógeno.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562213564P | 2015-09-02 | 2015-09-02 | |
| PCT/US2016/049439 WO2017040499A1 (en) | 2015-09-02 | 2016-08-30 | Glycoside hydolases and their use in preventing and/or treating a pathogenic infection in an animal |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2018002617A true MX2018002617A (es) | 2018-07-06 |
| MX382994B MX382994B (es) | 2025-03-13 |
Family
ID=56940378
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018002617A MX382994B (es) | 2015-09-02 | 2016-08-30 | Glucosido hidrolasas y su uso en la prevencion y/o tratamiento de infeccion patogena en un animal. |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US10933121B2 (es) |
| EP (2) | EP3344282B8 (es) |
| JP (1) | JP6914250B2 (es) |
| KR (1) | KR102711565B1 (es) |
| CN (1) | CN108348585B (es) |
| CA (1) | CA2997213C (es) |
| DK (1) | DK3344282T3 (es) |
| ES (1) | ES2835067T3 (es) |
| MX (1) | MX382994B (es) |
| PH (1) | PH12018500447B1 (es) |
| RU (1) | RU2720243C2 (es) |
| WO (1) | WO2017040499A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102225240B1 (ko) * | 2019-07-03 | 2021-03-10 | 경북대학교 산학협력단 | 다제내성 병원성 세균을 효과적으로 사멸시키는 재조합 항균 단백질 Ablysin의 용도 |
| EP4294426A1 (en) * | 2021-02-16 | 2023-12-27 | DSM IP Assets B.V. | Methods for reducing pathogenic e coli by selective feed additive intervention comprising enzymes such as muramidase |
| WO2023028454A1 (en) * | 2021-08-23 | 2023-03-02 | Dupont Nutrition Biosciences Aps | Feed additive compositions and methods for using the same |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0625577A1 (en) | 1985-08-29 | 1994-11-23 | Genencor International, Inc. | Heterologous polypeptides expressed in filamentous fungi, processes for their preparation, and vectors for their preparation |
| DK122686D0 (da) | 1986-03-17 | 1986-03-17 | Novo Industri As | Fremstilling af proteiner |
| GB8610600D0 (en) | 1986-04-30 | 1986-06-04 | Novo Industri As | Transformation of trichoderma |
| US5231020A (en) | 1989-03-30 | 1993-07-27 | Dna Plant Technology Corporation | Genetic engineering of novel plant phenotypes |
| ES2182818T5 (es) | 1990-12-10 | 2015-07-06 | Danisco Us Inc. | Sacarificación mejorada de celulosa por clonación y amplificación del gen de beta-glucosidasa de Trichoderma reesei |
| DK13491D0 (da) | 1991-01-25 | 1991-01-25 | Novo Nordisk As | Anvendelse af et enzymholdigt granulat og fremgangsmaade til fremstilling af et forderstof i tabletform |
| US5433946A (en) * | 1991-10-11 | 1995-07-18 | Health Research Inc. | Synthesis and utilization of therapeutic agents for the treatment of lysosomal storage diseases |
| WO1994025061A1 (en) * | 1993-04-23 | 1994-11-10 | Glyko, Inc. | Methods and compositions for treating diseases with carbohydrate modifying enzymes |
| US5861271A (en) | 1993-12-17 | 1999-01-19 | Fowler; Timothy | Cellulase enzymes and systems for their expressions |
| JP3167729B2 (ja) | 1994-06-30 | 2001-05-21 | ノボ ノルディスク バイオテック，インコーポレイティド | 無毒、非毒素原性、非病原性の発現系、並びにその中で利用するためのプロモーター及びターミネーター |
| AU7489896A (en) | 1995-11-02 | 1997-05-22 | Novo Nordisk A/S | Feed enzyme preparations |
| AU7428398A (en) | 1997-04-07 | 1998-10-30 | Unilever Plc | Agrobacterium mediated transformation of moulds, in particular those belonging to the genus aspergillus |
| RU2204609C2 (ru) * | 1997-05-20 | 2003-05-20 | Биотехнолоджи Резёрч Энд Девелопмент Корпорэйшен | СПОСОБ ИДЕНТИФИКАЦИИ СВИНЕЙ, РЕЗИСТЕНТНЫХ К КИШЕЧНЫМ ЗАБОЛЕВАНИЯМ, АССОЦИИРОВАННЫМ С Е.Сoli, СПОСОБ РАЗВЕДЕНИЯ СВИНЕЙ, РЕЗИСТЕНТНЫХ К КИШЕЧНЫМ ЗАБОЛЕВАНИЯМ, АССОЦИИРОВАННЫМ С E.Coli, ВЫДЕЛЕННАЯ ДНК-МОЛЕКУЛА (ВАРИАНТЫ), МОЛЕКУЛЯРНЫЙ АНАЛИЗ ДЛЯ ОБНАРУЖЕНИЯ РЕЦЕПТОРОВ Е.Сoli F-18 У СВИНЕЙ И НАБОР ДЛЯ ОБНАРУЖЕНИЯ РЕЦЕПТОРОВ Е.Сoli F-18 |
| US6268328B1 (en) | 1998-12-18 | 2001-07-31 | Genencor International, Inc. | Variant EGIII-like cellulase compositions |
| DE50015289D1 (de) | 1999-08-24 | 2008-09-11 | Henkel Ag & Co Kgaa | Verklebung durch Klebstoffe enthaltend nanoskalige Teilchen |
| RU2173556C1 (ru) | 2000-07-11 | 2001-09-20 | Жирков Игорь Николаевич | Способ лечения массовых диспепсий новорожденного молодняка крупного рогатого скота |
| US7232670B2 (en) * | 2001-09-28 | 2007-06-19 | St. Jude Children's Research Hospital | Targeting proteins to cells expressing mannose receptors via expression in insect cells |
| US6800472B2 (en) | 2001-12-21 | 2004-10-05 | Genzyme Glycobiology Research Institute, Inc. | Expression of lysosomal hydrolase in cells expressing pro-N-acetylglucosamine-1-phosphodiester α-N-acetyl glucosimanidase |
| ATE524491T1 (de) | 2003-05-29 | 2011-09-15 | Genencor Int | Neue trichoderma-gene |
| CA2548140A1 (en) * | 2003-12-05 | 2005-06-23 | University Of Massachusetts | Oligosaccharide compositions and use thereof in the treatment of infection |
| EP2497370A3 (en) | 2005-10-12 | 2013-11-20 | Danisco US Inc. | Stable, durable granules with active agents |
| EP2406381A4 (en) * | 2009-03-09 | 2012-08-29 | Qteros Inc | PRODUCTION OF TERMINAL FERMENTATION PRODUCTS OF CLOSTRIDIUM SPECIES |
| CN102703506A (zh) * | 2012-02-10 | 2012-10-03 | 安徽农业大学 | α1,2-岩藻糖转移酶基因沉默的体细胞克隆猪及其生产方法与应用 |
| BR112016002038A2 (pt) | 2013-07-29 | 2017-08-29 | Danisco Us Inc | Variantes de enzimas |
-
2016
- 2016-08-30 DK DK16766724.5T patent/DK3344282T3/da active
- 2016-08-30 RU RU2018111399A patent/RU2720243C2/ru active
- 2016-08-30 MX MX2018002617A patent/MX382994B/es unknown
- 2016-08-30 WO PCT/US2016/049439 patent/WO2017040499A1/en not_active Ceased
- 2016-08-30 PH PH1/2018/500447A patent/PH12018500447B1/en unknown
- 2016-08-30 EP EP16766724.5A patent/EP3344282B8/en active Active
- 2016-08-30 JP JP2018511724A patent/JP6914250B2/ja active Active
- 2016-08-30 ES ES16766724T patent/ES2835067T3/es active Active
- 2016-08-30 US US15/755,711 patent/US10933121B2/en active Active
- 2016-08-30 CA CA2997213A patent/CA2997213C/en active Active
- 2016-08-30 KR KR1020187009165A patent/KR102711565B1/ko active Active
- 2016-08-30 EP EP20161048.2A patent/EP3711773A1/en not_active Withdrawn
- 2016-08-30 CN CN201680063202.8A patent/CN108348585B/zh active Active
-
2021
- 2021-02-10 US US17/172,923 patent/US20210236606A1/en not_active Abandoned
-
2024
- 2024-02-28 US US18/590,736 patent/US20240325507A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| MX382994B (es) | 2025-03-13 |
| PH12018500447B1 (en) | 2022-11-11 |
| CN108348585A (zh) | 2018-07-31 |
| JP2018527357A (ja) | 2018-09-20 |
| EP3344282B8 (en) | 2020-12-23 |
| CN108348585B (zh) | 2023-12-15 |
| RU2018111399A3 (es) | 2019-10-28 |
| KR102711565B1 (ko) | 2024-09-27 |
| RU2720243C2 (ru) | 2020-04-28 |
| US20210236606A1 (en) | 2021-08-05 |
| CA2997213A1 (en) | 2017-03-09 |
| JP6914250B2 (ja) | 2021-08-04 |
| EP3711773A1 (en) | 2020-09-23 |
| RU2018111399A (ru) | 2019-10-02 |
| EP3344282B1 (en) | 2020-09-23 |
| KR20180043365A (ko) | 2018-04-27 |
| US20240325507A1 (en) | 2024-10-03 |
| DK3344282T3 (da) | 2020-12-14 |
| EP3344282A1 (en) | 2018-07-11 |
| PH12018500447A1 (en) | 2018-09-10 |
| WO2017040499A1 (en) | 2017-03-09 |
| ES2835067T3 (es) | 2021-06-21 |
| US10933121B2 (en) | 2021-03-02 |
| CA2997213C (en) | 2021-01-19 |
| US20190022193A1 (en) | 2019-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2018013557A2 (es) | Composiciones que comprenden cepas bacterianas | |
| BR112019012354A2 (pt) | anticorpos apenas de cadeia pesada anti-bcma | |
| UY37464A (es) | Métodos para tratar infecciones por el virus filoviridae | |
| AR106800A1 (es) | Composiciones que comprenden cepas bacterianas | |
| BR112018074001A2 (pt) | composição e método de tratamento de substratos | |
| AR106768A1 (es) | Composiciones que comprenden cepas bacterianas | |
| BR112017007301A2 (pt) | estruturas fibrosas solúveis e métodos para a fabricação das mesmas | |
| BR112017028318A2 (pt) | compostos antibacterianos | |
| MX2017008561A (es) | Novedoso bacteriófago clo-pep-1 de clostridium perfringens y su uso para inhibir la proliferación de clostridium perfringens. | |
| MX385401B (es) | Composiciones que contienen lipo-quitooligosacarido y microorganismo para potenciar el crecimiento de las plantas. | |
| MX382425B (es) | Imitadores de mir-29 y usos de los mismos | |
| EA201790571A1 (ru) | Пирролопиримидины для применения при инфекции, вызванной вирусом гриппа | |
| MX374452B (es) | Inhibidores de glucosilceramida sintasa para el tratamiento de enfermedades. | |
| MX2017007829A (es) | Composicion antimicrobiana. | |
| BR112016023815A2 (pt) | composições tópicas para o alívio da dor, produção e uso | |
| CL2016000326A1 (es) | Composiciones y método para tratar condiciones asociadas con el complemento | |
| BR112018004680A2 (pt) | método de tratamento de distúrbios de desenvolvimento | |
| DOP2016000336A (es) | Derivados de isoindolina para uso en el tratamiento de una infeccion viral | |
| BR112017012504A2 (pt) | derivados de piperidina como inibidores de hdac1/2 | |
| UY36373A (es) | Compuestos para usarse en el tratamiento antihelmíntico | |
| MX2017004198A (es) | Composiciones y equipos para tratar prurito y metodos para utilizar los mismos. | |
| MX2017004998A (es) | Composicion que contiene un extracto o fraccion de una planta del genero justicia. | |
| AR095483A1 (es) | Composición y método para prevenir, reducir, aliviar o tratar el vómito idiopático | |
| MX2017015926A (es) | Uso de derivados de bencimidazol para escape acido nocturno. | |
| UY36196A (es) | Compuestos para usar en el tratamiento antihelmíntico |